According to our latest research, the global primary cells market size in 2024 is valued at USD 1.62 billion, with a robust compound annual growth rate (CAGR) of 8.2% projected through the forecast period. By 2033, the market is anticipated to reach approximately USD 3.24 billion. This growth is primarily driven by increasing investments in cell-based research, rising demand for personalized medicine, and the expanding role of primary cells in drug discovery and regenerative medicine. As per our latest research, the surge in pharmaceutical R&D, coupled with advancements in cell isolation and culture techniques, is fueling the adoption of primary cells across various applications worldwide.
https://growthmarketreports.co....m/report/primary-cel
